[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353945-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353945-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-micrornas-in-modulating-wnt-signaling-pathway-dynamics-and-their-therapeutic-implications-in-non-small-cell-lung-cancer-review","The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer - Review","","Lung cancer ranks as the second most prevalent cancer worldwide and has the highest mortality among cancers. It comprises non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with NSCLC accounting for 80–85% of cases. The Wnt/β-catenin signaling pathway drives lung cancer initiation, progression, metastasis, and chemoresistance. MicroRNAs (miRNAs) modulate the tumor microenvironment by targeting genes that regulate proliferation, angiogenesis, and apoptosis, acting as oncogenes or tumor suppressors and serving as biomarker candidates. This review analyzes miRNAs that shape Wnt pathway components and their roles in NSCLC tumorigenesis, metastasis, and therapy resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-micrornas-in-modulating-wnt-signaling-pathway-dynamics-and-their-therapeutic-implications-in-non-small-cell-lung-cancer-review/353945/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-micrornas-in-modulating-wnt-signaling-pathway-dynamics-and-their-therapeutic-implications-in-non-small-cell-lung-cancer-review/353945.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does the Wnt/β-catenin pathway play in lung cancer according to the review?","Question",{"text":63,"@type":64},"The review states that the Wnt/β-catenin pathway is crucial for lung cancer initiation, progression, metastasis, and chemoresistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do microRNAs (miRNAs) influence the tumor microenvironment in this context?",{"text":68,"@type":64},"miRNAs modulate proliferation, angiogenesis, and apoptosis by targeting specific genes, and they can act either as oncogenes or tumor suppressors depending on their targets.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are miRNAs considered important for diagnosis and therapy in NSCLC?",{"text":72,"@type":64},"The review highlights miRNAs as novel biomarkers for cancer diagnosis and emphasizes their potential as therapeutic targets by affecting Wnt pathway components involved in tumorigenesis, metastasis, and therapy resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353945,1790132290,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Wang et al. Discover Oncology (2026) 17:510 [https://doi.org/10.1007/s12672-025-04358-2](https://doi.org/10.1007/s12672-025-04358-2)  \nDiscover Oncology  \nREVIEW Open Access  \nThe role of microRNAs in modulating Wnt  signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer  \nYahui Wang1, Saodat Yarmukhamedova2, Rawaa Najim Alkhamessi3, Mustafa Jawad Kadham4, Raed Fanoukh AAboqader Al-Aouadi5, Vishal Thakur6, Rana Hussein Naser7, Natrayan Lakshmaiya8, Premkumar Jayapal9,10, Wesam Taher Almagharbeh11, Ioan Sârbu12*, Fitra Ari Aditya13, Carmen Iulia Ciongradi12 and Sina Hamzehzadeh 14*  \n*Correspondence: Ioan Sârbu[sarbu.ioan@umfiasi. ro](sarbu.ioan@umfiasi. ro)[ ](sarbu.ioan@umfiasi. ro)Sina Hamzehzadeh  \n[Hamzehzadehsina.shz@yahoo.com](Hamzehzadehsina.shz@yahoo.com)[ ](Hamzehzadehsina.shz@yahoo.com)Full list of author information is available at the end of the article  \nAbstract  \nLung cancer ranks as the second most prevalent cancer worldwide and exhibits the highest mortality rate among all cancers. It primarily consists of two subtypes:  \nnon-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with NSCLC representing 80–85% of cases. The Wnt/β-catenin signaling pathway is crucial in lung cancer initiation, progression, metastasis, and chemoresistance. MicroRNAs (miRNAs), small non-coding RNAs, significantly influence the tumor microenvironment by modulating cancer cell proliferation, angiogenesis, and apoptosis through the targeting of specific genes. Depending on their targets, miRNAs can function as oncogenes or tumor suppressors, highlighting their potential as therapeutic targets. Additionally, miRNAs serve as novel biomarkers for cancer diagnosis. Understanding the key miRNAs involved in lung cancer and their interactions with pathways like Wntis essential for developing new diagnostic and therapeutic approaches. This review focuses on how specific miRNAs affect the Wnt pathway's components and their roles in tumorigenesis, metastasis, and therapy resistance, emphasizing their potential as therapeutic targets in NSCLC. Ultimately, this review aims to improve clinical outcomes and facilitate personalized therapeutic approaches for this aggressive malignancy.  \nKeywords Lung cancer, Non-small cell lung cancer, microRNA, Wnt pathway, Biomarker  \n1 Introduction  \nLung cancer (LC) is reported as the second most common cancer and has the highest mortality rate among different types of cancers [1, 2]. Currently, the five-year survival rate for patients with LC is merely 19%, with 57% diagnosed at an advanced stage, resulting in a 5-year survival rate of only 5%[3, 4]. Pathologically, LC has two main types:  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nWang et al. Discover Oncology (2026) 17:510 Page 2 of 23  \nGraphical Abstract  \nSmall Cell Lung Cancer (SCLC) and Non-SCLC (NSCLC). SCLC is more metastatic and accounts for about 15% of LC cases, while NSCLC accounts","cbCaiuWguBPVGhrk","https://ap.wps.com/l/cbCaiuWguBPVGhrk","pdf",2275109,23,"English","# Abstract\n# 1 Introduction\n## Lung cancer epidemiology and subtypes\n## Wnt/β-catenin pathway in cancer\n## microRNAs as regulators and therapeutic targets\n# Graphical Abstract","[{\"question\":\"What role does the Wnt/β-catenin pathway play in lung cancer according to the review?\",\"answer\":\"The review states that the Wnt/β-catenin pathway is crucial for lung cancer initiation, progression, metastasis, and chemoresistance.\"},{\"question\":\"How do microRNAs (miRNAs) influence the tumor microenvironment in this context?\",\"answer\":\"miRNAs modulate proliferation, angiogenesis, and apoptosis by targeting specific genes, and they can act either as oncogenes or tumor suppressors depending on their targets.\"},{\"question\":\"Why are miRNAs considered important for diagnosis and therapy in NSCLC?\",\"answer\":\"The review highlights miRNAs as novel biomarkers for cancer diagnosis and emphasizes their potential as therapeutic targets by affecting Wnt pathway components involved in tumorigenesis, metastasis, and therapy resistance.\"}]","The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer - Review | PDF",1790108083,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3865fc1deaea46a4c086da83b0ec46af.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5df1598ec291f2f3c0a02230adc05a4a.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01c0344153be19bb848c2e7854cd0827.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a176de2bb8252738e2a2cbe61656d8e.webp",980,1306]